

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.05717901 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.05717901 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.96401881 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.96401881 |
| 5 | Golgi transport vesicle coating (GO:0048200) | 5.09112609 |
| 6 | COPI coating of Golgi vesicle (GO:0048205) | 5.09112609 |
| 7 | serine family amino acid catabolic process (GO:0009071) | 4.86764632 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 4.75654184 |
| 9 | glycine metabolic process (GO:0006544) | 4.63439535 |
| 10 | glyoxylate metabolic process (GO:0046487) | 4.57033109 |
| 11 | sulfur amino acid catabolic process (GO:0000098) | 4.28173210 |
| 12 | tryptophan metabolic process (GO:0006568) | 4.26142797 |
| 13 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.24058726 |
| 14 | kynurenine metabolic process (GO:0070189) | 4.21300584 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.10504568 |
| 16 | serine family amino acid metabolic process (GO:0009069) | 4.03197350 |
| 17 | lysine catabolic process (GO:0006554) | 4.02769431 |
| 18 | lysine metabolic process (GO:0006553) | 4.02769431 |
| 19 | aromatic amino acid family metabolic process (GO:0009072) | 4.01159134 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 3.97355786 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 3.97355786 |
| 22 | tryptophan catabolic process (GO:0006569) | 3.97355786 |
| 23 | bile acid biosynthetic process (GO:0006699) | 3.95083420 |
| 24 | cysteine metabolic process (GO:0006534) | 3.94320004 |
| 25 | pantothenate metabolic process (GO:0015939) | 3.91169822 |
| 26 | cellular ketone body metabolic process (GO:0046950) | 3.82823793 |
| 27 | serine family amino acid biosynthetic process (GO:0009070) | 3.80241970 |
| 28 | biotin metabolic process (GO:0006768) | 3.79366320 |
| 29 | 2-oxoglutarate metabolic process (GO:0006103) | 3.78777141 |
| 30 | alpha-amino acid catabolic process (GO:1901606) | 3.75527464 |
| 31 | tyrosine metabolic process (GO:0006570) | 3.75208108 |
| 32 | branched-chain amino acid catabolic process (GO:0009083) | 3.71724590 |
| 33 | stress fiber assembly (GO:0043149) | 3.68562706 |
| 34 | cellular amino acid catabolic process (GO:0009063) | 3.66275852 |
| 35 | sperm capacitation (GO:0048240) | 3.64068045 |
| 36 | valine metabolic process (GO:0006573) | 3.59717419 |
| 37 | homocysteine metabolic process (GO:0050667) | 3.56112765 |
| 38 | aspartate family amino acid catabolic process (GO:0009068) | 3.52275007 |
| 39 | S-adenosylmethionine metabolic process (GO:0046500) | 3.48886905 |
| 40 | negative regulation of fibrinolysis (GO:0051918) | 3.48301702 |
| 41 | high-density lipoprotein particle remodeling (GO:0034375) | 3.47790862 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 3.46568622 |
| 43 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.45976017 |
| 44 | regulation of fibrinolysis (GO:0051917) | 3.45214072 |
| 45 | branched-chain amino acid metabolic process (GO:0009081) | 3.43163114 |
| 46 | bile acid metabolic process (GO:0008206) | 3.40263048 |
| 47 | L-serine metabolic process (GO:0006563) | 3.39614684 |
| 48 | coenzyme catabolic process (GO:0009109) | 3.39417190 |
| 49 | cellular modified amino acid catabolic process (GO:0042219) | 3.37783221 |
| 50 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.36841469 |
| 51 | organic acid catabolic process (GO:0016054) | 3.34423297 |
| 52 | carboxylic acid catabolic process (GO:0046395) | 3.34423297 |
| 53 | fatty acid catabolic process (GO:0009062) | 3.32084316 |
| 54 | protein carboxylation (GO:0018214) | 3.30444416 |
| 55 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.30444416 |
| 56 | protein localization to endosome (GO:0036010) | 3.30379303 |
| 57 | ketone body metabolic process (GO:1902224) | 3.29346121 |
| 58 | alpha-linolenic acid metabolic process (GO:0036109) | 3.29227938 |
| 59 | regulation of protein activation cascade (GO:2000257) | 3.25788594 |
| 60 | amino acid salvage (GO:0043102) | 3.25759268 |
| 61 | L-methionine salvage (GO:0071267) | 3.25759268 |
| 62 | L-methionine biosynthetic process (GO:0071265) | 3.25759268 |
| 63 | vitamin transmembrane transport (GO:0035461) | 3.24392844 |
| 64 | NADH metabolic process (GO:0006734) | 3.23875985 |
| 65 | sexual reproduction (GO:0019953) | 3.20315959 |
| 66 | urea cycle (GO:0000050) | 3.20260817 |
| 67 | urea metabolic process (GO:0019627) | 3.20260817 |
| 68 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.19686709 |
| 69 | blood coagulation, intrinsic pathway (GO:0007597) | 3.18165757 |
| 70 | monocarboxylic acid catabolic process (GO:0072329) | 3.17502528 |
| 71 | sulfur amino acid biosynthetic process (GO:0000097) | 3.14620059 |
| 72 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.13785723 |
| 73 | fatty acid beta-oxidation (GO:0006635) | 3.13569159 |
| 74 | mannose metabolic process (GO:0006013) | 3.11301854 |
| 75 | negative regulation of cholesterol transport (GO:0032375) | 3.11267646 |
| 76 | negative regulation of sterol transport (GO:0032372) | 3.11267646 |
| 77 | indolalkylamine metabolic process (GO:0006586) | 3.10272238 |
| 78 | sulfur amino acid metabolic process (GO:0000096) | 3.10219126 |
| 79 | cell volume homeostasis (GO:0006884) | 3.07627847 |
| 80 | short-chain fatty acid metabolic process (GO:0046459) | 3.07609615 |
| 81 | regulation of oxidative phosphorylation (GO:0002082) | 3.05717438 |
| 82 | complement activation, alternative pathway (GO:0006957) | 3.05581641 |
| 83 | glutamate metabolic process (GO:0006536) | 3.04624451 |
| 84 | regulation of complement activation (GO:0030449) | 3.04106096 |
| 85 | acetyl-CoA metabolic process (GO:0006084) | 3.03334716 |
| 86 | fatty acid oxidation (GO:0019395) | 3.02906080 |
| 87 | regulation of cholesterol metabolic process (GO:0090181) | 3.01354942 |
| 88 | drug transmembrane transport (GO:0006855) | 3.00552335 |
| 89 | regulation of cholesterol esterification (GO:0010872) | 3.00269789 |
| 90 | protein targeting to lysosome (GO:0006622) | 2.97965848 |
| 91 | establishment of protein localization to vacuole (GO:0072666) | 2.97965848 |
| 92 | protein targeting to vacuole (GO:0006623) | 2.97965848 |
| 93 | cell-cell junction maintenance (GO:0045217) | 2.97928988 |
| 94 | lipid oxidation (GO:0034440) | 2.95872778 |
| 95 | amine catabolic process (GO:0009310) | 2.95478429 |
| 96 | cellular biogenic amine catabolic process (GO:0042402) | 2.95478429 |
| 97 | folic acid metabolic process (GO:0046655) | 2.95014735 |
| 98 | regulation of triglyceride catabolic process (GO:0010896) | 2.94661057 |
| 99 | actin filament depolymerization (GO:0030042) | 2.93807613 |
| 100 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.93145976 |
| 101 | acylglycerol homeostasis (GO:0055090) | 2.92209961 |
| 102 | triglyceride homeostasis (GO:0070328) | 2.92209961 |
| 103 | nitrogen cycle metabolic process (GO:0071941) | 2.91928099 |
| 104 | glucose 6-phosphate metabolic process (GO:0051156) | 2.91825640 |
| 105 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.91728312 |
| 106 | reverse cholesterol transport (GO:0043691) | 2.91632269 |
| 107 | urate metabolic process (GO:0046415) | 2.90967742 |
| 108 | heme transport (GO:0015886) | 2.90101883 |
| 109 | aspartate family amino acid metabolic process (GO:0009066) | 2.87135283 |
| 110 | bile acid and bile salt transport (GO:0015721) | 2.84777223 |
| 111 | plasma lipoprotein particle remodeling (GO:0034369) | 2.83461846 |
| 112 | protein-lipid complex remodeling (GO:0034368) | 2.83461846 |
| 113 | macromolecular complex remodeling (GO:0034367) | 2.83461846 |
| 114 | peptidyl-proline hydroxylation (GO:0019511) | 2.83182193 |
| 115 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.83083782 |
| 116 | regulation of early endosome to late endosome transport (GO:2000641) | 2.81896515 |
| 117 | GMP metabolic process (GO:0046037) | 2.81426466 |
| 118 | small molecule catabolic process (GO:0044282) | 2.81355521 |
| 119 | cofactor catabolic process (GO:0051187) | 2.80828283 |
| 120 | tricarboxylic acid metabolic process (GO:0072350) | 2.78312919 |
| 121 | regulation of ARF protein signal transduction (GO:0032012) | 2.73807089 |
| 122 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.72562754 |
| 123 | negative regulation of insulin receptor signaling pathway (GO:0046627) | 2.66626584 |
| 124 | protein targeting to plasma membrane (GO:0072661) | 2.65508522 |
| 125 | 4-hydroxyproline metabolic process (GO:0019471) | 2.64301207 |
| 126 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.63884203 |
| 127 | peptide catabolic process (GO:0043171) | 2.63520251 |
| 128 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.61388540 |
| 129 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.61388540 |
| 130 | vesicle coating (GO:0006901) | 2.55125384 |
| 131 | barbed-end actin filament capping (GO:0051016) | 2.53870282 |
| 132 | regulation of ARF GTPase activity (GO:0032312) | 2.53553727 |
| 133 | COPII vesicle coating (GO:0048208) | 2.52329954 |
| 134 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.52089947 |
| 135 | microtubule severing (GO:0051013) | 2.50222188 |
| 136 | adhesion of symbiont to host cell (GO:0044650) | 2.48587823 |
| 137 | virion attachment to host cell (GO:0019062) | 2.48587823 |
| 138 | regulation of autophagic vacuole assembly (GO:2000785) | 2.47693099 |
| 139 | regulation of histone H3-K27 methylation (GO:0061085) | 2.47370009 |
| 140 | establishment of endothelial barrier (GO:0061028) | 2.47138870 |
| 141 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 2.45423120 |
| 142 | adhesion of symbiont to host (GO:0044406) | 2.43541446 |
| 143 | positive regulation of type 2 immune response (GO:0002830) | 2.43069292 |
| 144 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.41914985 |
| 145 | regulation of insulin receptor signaling pathway (GO:0046626) | 2.39780923 |
| 146 | amyloid precursor protein catabolic process (GO:0042987) | 2.39503378 |
| 147 | membrane protein ectodomain proteolysis (GO:0006509) | 2.38159191 |
| 148 | epithelial cell-cell adhesion (GO:0090136) | 2.36283852 |
| 149 | regulation of Rho protein signal transduction (GO:0035023) | 2.36131539 |
| 150 | cardiolipin metabolic process (GO:0032048) | 2.36131130 |
| 151 | embryonic process involved in female pregnancy (GO:0060136) | 2.35648498 |
| 152 | peptidyl-lysine dimethylation (GO:0018027) | 2.31283380 |
| 153 | protein retention in ER lumen (GO:0006621) | 2.30042440 |
| 154 | basement membrane organization (GO:0071711) | 2.29923927 |
| 155 | cell junction maintenance (GO:0034331) | 2.29307674 |
| 156 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.27274827 |
| 157 | membrane budding (GO:0006900) | 2.25019187 |
| 158 | Rap protein signal transduction (GO:0032486) | 2.24136273 |
| 159 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.24028047 |
| 160 | positive regulation of receptor recycling (GO:0001921) | 2.22637230 |
| 161 | regulation of mononuclear cell migration (GO:0071675) | 2.22555024 |
| 162 | pinocytosis (GO:0006907) | 2.21897678 |
| 163 | positive regulation of Rap GTPase activity (GO:0032854) | 2.20172989 |
| 164 | eosinophil chemotaxis (GO:0048245) | 2.20103928 |
| 165 | localization within membrane (GO:0051668) | 2.19692074 |
| 166 | response to thyroid hormone (GO:0097066) | 2.19415904 |
| 167 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.19128155 |
| 168 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.18944194 |
| 169 | negative regulation of inclusion body assembly (GO:0090084) | 2.16581695 |
| 170 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.16548101 |
| 171 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.15788383 |
| 172 | regulation of vacuole organization (GO:0044088) | 2.14860991 |
| 173 | apoptotic cell clearance (GO:0043277) | 2.14717730 |
| 174 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.14143762 |
| 175 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.13363751 |
| 176 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.12890619 |
| 177 | sodium ion export (GO:0071436) | 2.12490703 |
| 178 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.12462611 |
| 179 | regulation of cellular amide metabolic process (GO:0034248) | 2.12114085 |
| 180 | regulation of cellular response to insulin stimulus (GO:1900076) | 2.12033133 |
| 181 | protein hydroxylation (GO:0018126) | 2.11833536 |
| 182 | receptor recycling (GO:0001881) | 2.10833230 |
| 183 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.10771671 |
| 184 | sphingomyelin metabolic process (GO:0006684) | 2.10110848 |
| 185 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.08208631 |
| 186 | retrograde transport, endosome to Golgi (GO:0042147) | 2.07361003 |
| 187 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.07172592 |
| 188 | skin morphogenesis (GO:0043589) | 2.06080539 |
| 189 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.05457091 |
| 190 | protein depolymerization (GO:0051261) | 2.05402894 |
| 191 | response to acidic pH (GO:0010447) | 2.05330388 |
| 192 | ruffle organization (GO:0031529) | 2.05080625 |
| 193 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.04950245 |
| 194 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.04427258 |
| 195 | regulation of inclusion body assembly (GO:0090083) | 2.04258465 |
| 196 | glomerular basement membrane development (GO:0032836) | 2.03965431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.32240214 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.79934412 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.21364511 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.14827598 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.65593309 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.47057198 |
| 7 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.41430697 |
| 8 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.25562112 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.20622235 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.93775185 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.79017794 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.70964169 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.62933590 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.38482388 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.32167369 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.31779205 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.27640519 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.25907701 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.19271048 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.17387344 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.10423107 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.08041700 |
| 23 | * CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.06872547 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.02212542 |
| 25 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.01637104 |
| 26 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.98547488 |
| 27 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.98200679 |
| 28 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.95482139 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.93661928 |
| 30 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.91974967 |
| 31 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.91471631 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.90290211 |
| 33 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.88031635 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83502668 |
| 35 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.83299279 |
| 36 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.83206550 |
| 37 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.81919504 |
| 38 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.81761547 |
| 39 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.76378411 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.70998764 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.70484520 |
| 42 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.69417152 |
| 43 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.67724728 |
| 44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.63261084 |
| 45 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.62656240 |
| 46 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.62053869 |
| 47 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.61910869 |
| 48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.61351446 |
| 49 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.59936595 |
| 50 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56814965 |
| 51 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.56615821 |
| 52 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47205456 |
| 53 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.46025960 |
| 54 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45649000 |
| 55 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44743401 |
| 56 | GATA1_19941826_ChIP-Seq_K562_Human | 1.44502574 |
| 57 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.44278546 |
| 58 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.44124797 |
| 59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.43157461 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.40883314 |
| 61 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40643368 |
| 62 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.39990236 |
| 63 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.39738644 |
| 64 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.39320926 |
| 65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39160716 |
| 66 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.37973736 |
| 67 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.37193900 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36626502 |
| 69 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.35175193 |
| 70 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.33226950 |
| 71 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.33004094 |
| 72 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31401371 |
| 73 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30445342 |
| 74 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.30085142 |
| 75 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.30052441 |
| 76 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.29726873 |
| 77 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.28902447 |
| 78 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28748596 |
| 79 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.28741111 |
| 80 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.27461618 |
| 81 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.25203000 |
| 82 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.23516783 |
| 83 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21520723 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21282309 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20861622 |
| 86 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20282969 |
| 87 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.19764306 |
| 88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19545112 |
| 89 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.19361861 |
| 90 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.19288076 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18404242 |
| 92 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.18276232 |
| 93 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.18232459 |
| 94 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.17659637 |
| 95 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.17215547 |
| 96 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.16941859 |
| 97 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16108867 |
| 98 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16108867 |
| 99 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15097205 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14907417 |
| 101 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.14493890 |
| 102 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13814688 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13552455 |
| 104 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.13439202 |
| 105 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13358145 |
| 106 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.13071492 |
| 107 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.12928216 |
| 108 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.11993374 |
| 109 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.11648335 |
| 110 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.10916484 |
| 111 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10793241 |
| 112 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10457831 |
| 113 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09166555 |
| 114 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.08963663 |
| 115 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08708064 |
| 116 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06676127 |
| 117 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.06615151 |
| 118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06536354 |
| 119 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06480466 |
| 120 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06417805 |
| 121 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05775056 |
| 122 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.05507233 |
| 123 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.05478652 |
| 124 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05444791 |
| 125 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.04863163 |
| 126 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03596991 |
| 127 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03582486 |
| 128 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.03061691 |
| 129 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02195546 |
| 130 | MYC_22102868_ChIP-Seq_BL_Human | 1.02072596 |
| 131 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02040790 |
| 132 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01370379 |
| 133 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.01218268 |
| 134 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.98567218 |
| 135 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97544326 |
| 136 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97514602 |
| 137 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.96224071 |
| 138 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95820768 |
| 139 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94051347 |
| 140 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93137691 |
| 141 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92710074 |
| 142 | P68_20966046_ChIP-Seq_HELA_Human | 0.92496738 |
| 143 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.90766994 |
| 144 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.90689224 |
| 145 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.90009885 |
| 146 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.86576737 |
| 147 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.86260177 |
| 148 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.85065295 |
| 149 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.84988904 |
| 150 | ERA_21632823_ChIP-Seq_H3396_Human | 0.84604397 |
| 151 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84598390 |
| 152 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.83658353 |
| 153 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.83556286 |
| 154 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.83496809 |
| 155 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82880540 |
| 156 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.82378444 |
| 157 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.82360852 |
| 158 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.81670677 |
| 159 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.80122125 |
| 160 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.78823320 |
| 161 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.78598088 |
| 162 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.78318905 |
| 163 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.78030023 |
| 164 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.77996849 |
| 165 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.77744789 |
| 166 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.75431914 |
| 167 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.75226624 |
| 168 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.75167090 |
| 169 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.75068028 |
| 170 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.74686861 |
| 171 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.74644571 |
| 172 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.73827271 |
| 173 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.73584838 |
| 174 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.70436928 |
| 175 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.70281844 |
| 176 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.70148184 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.98710366 |
| 2 | MP0005360_urolithiasis | 5.08313490 |
| 3 | MP0005365_abnormal_bile_salt | 4.96693338 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.81168671 |
| 5 | MP0000569_abnormal_digit_pigmentation | 4.39784981 |
| 6 | MP0009840_abnormal_foam_cell | 4.10180440 |
| 7 | MP0003172_abnormal_lysosome_physiology | 3.97797930 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.71998532 |
| 9 | MP0003303_peritoneal_inflammation | 3.40939761 |
| 10 | MP0005083_abnormal_biliary_tract | 3.16483893 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.99583947 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.94833453 |
| 13 | MP0003566_abnormal_cell_adhesion | 2.70148984 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.69428160 |
| 15 | MP0005332_abnormal_amino_acid | 2.68747029 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.55413294 |
| 17 | MP0000015_abnormal_ear_pigmentation | 2.54712116 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.36559552 |
| 19 | MP0001958_emphysema | 2.25876974 |
| 20 | MP0003252_abnormal_bile_duct | 2.19685370 |
| 21 | MP0006082_CNS_inflammation | 2.06129791 |
| 22 | MP0003195_calcinosis | 2.04770308 |
| 23 | MP0006036_abnormal_mitochondrial_physio | 2.03424296 |
| 24 | MP0004858_abnormal_nervous_system | 1.98242592 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.90591379 |
| 26 | MP0009697_abnormal_copulation | 1.88328492 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 1.84595235 |
| 28 | MP0003091_abnormal_cell_migration | 1.80075252 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 1.73472550 |
| 30 | MP0003868_abnormal_feces_composition | 1.70533089 |
| 31 | MP0005220_abnormal_exocrine_pancreas | 1.70036506 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.67301613 |
| 33 | MP0000609_abnormal_liver_physiology | 1.65140854 |
| 34 | MP0003279_aneurysm | 1.60166021 |
| 35 | MP0005410_abnormal_fertilization | 1.57792269 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.57447755 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.52963443 |
| 38 | MP0004233_abnormal_muscle_weight | 1.50106257 |
| 39 | MP0000467_abnormal_esophagus_morphology | 1.48489945 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.48285785 |
| 41 | MP0005451_abnormal_body_composition | 1.47371551 |
| 42 | MP0004043_abnormal_pH_regulation | 1.46987041 |
| 43 | MP0002877_abnormal_melanocyte_morpholog | 1.46215235 |
| 44 | MP0005636_abnormal_mineral_homeostasis | 1.44796908 |
| 45 | MP0001764_abnormal_homeostasis | 1.44143834 |
| 46 | MP0005408_hypopigmentation | 1.41375586 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.39843304 |
| 48 | MP0003724_increased_susceptibility_to | 1.38974713 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 1.37433112 |
| 50 | MP0008961_abnormal_basal_metabolism | 1.36198083 |
| 51 | MP0003436_decreased_susceptibility_to | 1.35605296 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.34066426 |
| 53 | MP0000678_abnormal_parathyroid_gland | 1.33677260 |
| 54 | MP0005670_abnormal_white_adipose | 1.32306668 |
| 55 | MP0003690_abnormal_glial_cell | 1.31969643 |
| 56 | MP0003879_abnormal_hair_cell | 1.30896157 |
| 57 | MP0000747_muscle_weakness | 1.30248827 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.28554652 |
| 59 | MP0005409_darkened_coat_color | 1.28240687 |
| 60 | MP0009379_abnormal_foot_pigmentation | 1.27452917 |
| 61 | MP0002295_abnormal_pulmonary_circulatio | 1.26382668 |
| 62 | MP0003123_paternal_imprinting | 1.24480358 |
| 63 | MP0003329_amyloid_beta_deposits | 1.23377841 |
| 64 | MP0004264_abnormal_extraembryonic_tissu | 1.23274167 |
| 65 | MP0002254_reproductive_system_inflammat | 1.23267755 |
| 66 | MP0001849_ear_inflammation | 1.23042369 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.22476481 |
| 68 | MP0003300_gastrointestinal_ulcer | 1.22137963 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.20667040 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.20667040 |
| 71 | MP0002078_abnormal_glucose_homeostasis | 1.19926079 |
| 72 | MP0001661_extended_life_span | 1.19423962 |
| 73 | MP0002909_abnormal_adrenal_gland | 1.18797568 |
| 74 | MP0001944_abnormal_pancreas_morphology | 1.17081731 |
| 75 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.16731044 |
| 76 | MP0002638_abnormal_pupillary_reflex | 1.15380857 |
| 77 | MP0000751_myopathy | 1.15060592 |
| 78 | MP0005166_decreased_susceptibility_to | 1.13367680 |
| 79 | MP0004036_abnormal_muscle_relaxation | 1.13050875 |
| 80 | MP0005330_cardiomyopathy | 1.12496339 |
| 81 | MP0005623_abnormal_meninges_morphology | 1.12014700 |
| 82 | MP0000858_altered_metastatic_potential | 1.11974535 |
| 83 | MP0001533_abnormal_skeleton_physiology | 1.10008844 |
| 84 | MP0004947_skin_inflammation | 1.09931930 |
| 85 | MP0005058_abnormal_lysosome_morphology | 1.09099894 |
| 86 | MP0001765_abnormal_ion_homeostasis | 1.08643899 |
| 87 | MP0005174_abnormal_tail_pigmentation | 1.07392120 |
| 88 | MP0003186_abnormal_redox_activity | 1.05814427 |
| 89 | MP0005257_abnormal_intraocular_pressure | 1.03514548 |
| 90 | MP0002269_muscular_atrophy | 1.02421047 |
| 91 | MP0001756_abnormal_urination | 1.02216442 |
| 92 | MP0009780_abnormal_chondrocyte_physiolo | 1.01603432 |
| 93 | MP0003718_maternal_effect | 1.01209387 |
| 94 | MP0001348_abnormal_lacrimal_gland | 0.99294708 |
| 95 | MP0003878_abnormal_ear_physiology | 0.98818789 |
| 96 | MP0005377_hearing/vestibular/ear_phenot | 0.98818789 |
| 97 | MP0005084_abnormal_gallbladder_morpholo | 0.98450027 |
| 98 | MP0003828_pulmonary_edema | 0.97643786 |
| 99 | MP0002971_abnormal_brown_adipose | 0.97574824 |
| 100 | MP0000249_abnormal_blood_vessel | 0.96462172 |
| 101 | MP0005666_abnormal_adipose_tissue | 0.95633713 |
| 102 | MP0000343_altered_response_to | 0.95438860 |
| 103 | MP0003075_altered_response_to | 0.95100743 |
| 104 | MP0003183_abnormal_peptide_metabolism | 0.95044173 |
| 105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94392233 |
| 106 | MP0003011_delayed_dark_adaptation | 0.93207118 |
| 107 | MP0000371_diluted_coat_color | 0.92371681 |
| 108 | MP0004510_myositis | 0.91805859 |
| 109 | MP0000013_abnormal_adipose_tissue | 0.91369009 |
| 110 | MP0005501_abnormal_skin_physiology | 0.91227306 |
| 111 | MP0005023_abnormal_wound_healing | 0.89792606 |
| 112 | MP0005535_abnormal_body_temperature | 0.89515289 |
| 113 | MP0004215_abnormal_myocardial_fiber | 0.89230113 |
| 114 | MP0005379_endocrine/exocrine_gland_phen | 0.88898986 |
| 115 | MP0002419_abnormal_innate_immunity | 0.88296082 |
| 116 | MP0004185_abnormal_adipocyte_glucose | 0.86623961 |
| 117 | MP0000920_abnormal_myelination | 0.85646447 |
| 118 | MP0009672_abnormal_birth_weight | 0.84659398 |
| 119 | MP0000230_abnormal_systemic_arterial | 0.83996480 |
| 120 | MP0003638_abnormal_response/metabolism_ | 0.83863065 |
| 121 | MP0003137_abnormal_impulse_conducting | 0.83859661 |
| 122 | MP0005025_abnormal_response_to | 0.82905261 |
| 123 | MP0001529_abnormal_vocalization | 0.82676908 |
| 124 | MP0008260_abnormal_autophagy | 0.82162445 |
| 125 | MP0004859_abnormal_synaptic_plasticity | 0.81795359 |
| 126 | MP0009115_abnormal_fat_cell | 0.79958721 |
| 127 | MP0004145_abnormal_muscle_electrophysio | 0.79231566 |
| 128 | MP0003646_muscle_fatigue | 0.78935229 |
| 129 | MP0000598_abnormal_liver_morphology | 0.78306212 |
| 130 | MP0004084_abnormal_cardiac_muscle | 0.78117416 |
| 131 | MP0009278_abnormal_bone_marrow | 0.75599257 |
| 132 | MP0009642_abnormal_blood_homeostasis | 0.75568988 |
| 133 | MP0000750_abnormal_muscle_regeneration | 0.75557623 |
| 134 | MP0002168_other_aberrant_phenotype | 0.75167066 |
| 135 | MP0002089_abnormal_postnatal_growth/wei | 0.74858908 |
| 136 | MP0000462_abnormal_digestive_system | 0.74470707 |
| 137 | MP0004147_increased_porphyrin_level | 0.74345932 |
| 138 | MP0005266_abnormal_metabolism | 0.72442678 |
| 139 | MP0002693_abnormal_pancreas_physiology | 0.72181540 |
| 140 | MP0002822_catalepsy | 0.71782109 |
| 141 | MP0002896_abnormal_bone_mineralization | 0.71227173 |
| 142 | MP0003953_abnormal_hormone_level | 0.70158203 |
| 143 | MP0010155_abnormal_intestine_physiology | 0.69796796 |
| 144 | MP0005375_adipose_tissue_phenotype | 0.67972994 |
| 145 | MP0005647_abnormal_sex_gland | 0.67882899 |
| 146 | MP0000566_synostosis | 0.67104305 |
| 147 | MP0006138_congestive_heart_failure | 0.66156577 |
| 148 | MP0000749_muscle_degeneration | 0.65837555 |
| 149 | MP0000604_amyloidosis | 0.64140598 |
| 150 | MP0005167_abnormal_blood-brain_barrier | 0.64095855 |
| 151 | MP0005165_increased_susceptibility_to | 0.62835297 |
| 152 | MP0009785_altered_susceptibility_to | 0.62684233 |
| 153 | MP0005448_abnormal_energy_balance | 0.62648080 |
| 154 | MP0005076_abnormal_cell_differentiation | 0.61680066 |
| 155 | MP0004085_abnormal_heartbeat | 0.61645674 |
| 156 | MP0005376_homeostasis/metabolism_phenot | 0.59619072 |
| 157 | MP0002132_abnormal_respiratory_system | 0.59427572 |
| 158 | MP0000358_abnormal_cell_content/ | 0.58225437 |
| 159 | MP0000639_abnormal_adrenal_gland | 0.58076129 |
| 160 | MP0004142_abnormal_muscle_tone | 0.57464061 |
| 161 | MP0002229_neurodegeneration | 0.57196672 |
| 162 | MP0003959_abnormal_lean_body | 0.55099688 |
| 163 | MP0001664_abnormal_digestion | 0.52747622 |
| 164 | MP0001905_abnormal_dopamine_level | 0.50402673 |
| 165 | MP0005452_abnormal_adipose_tissue | 0.49870004 |
| 166 | MP0002970_abnormal_white_adipose | 0.49747521 |
| 167 | MP0004270_analgesia | 0.49473097 |
| 168 | MP0000003_abnormal_adipose_tissue | 0.49368814 |
| 169 | MP0000681_abnormal_thyroid_gland | 0.47076375 |
| 170 | MP0010678_abnormal_skin_adnexa | 0.46898382 |
| 171 | MP0006276_abnormal_autonomic_nervous | 0.46639382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.45208799 |
| 2 | Hyperglycinemia (HP:0002154) | 5.00514553 |
| 3 | Hyperglycinuria (HP:0003108) | 4.74738128 |
| 4 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.29966933 |
| 5 | Abnormality of glycine metabolism (HP:0010895) | 4.29966933 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 4.09562194 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.06674026 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 3.98336570 |
| 9 | Xanthomatosis (HP:0000991) | 3.94953644 |
| 10 | Deep venous thrombosis (HP:0002625) | 3.93067469 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 3.87132271 |
| 12 | Gout (HP:0001997) | 3.77575483 |
| 13 | Ketosis (HP:0001946) | 3.65224514 |
| 14 | Vascular calcification (HP:0004934) | 3.65128381 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 3.64186095 |
| 16 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.63222175 |
| 17 | Abnormal gallbladder physiology (HP:0012438) | 3.59611667 |
| 18 | Cholecystitis (HP:0001082) | 3.59611667 |
| 19 | Hyperammonemia (HP:0001987) | 3.51486871 |
| 20 | Cardiovascular calcification (HP:0011915) | 3.43608231 |
| 21 | Ketoacidosis (HP:0001993) | 3.30458017 |
| 22 | Distal upper limb amyotrophy (HP:0007149) | 3.26380130 |
| 23 | Upper limb amyotrophy (HP:0009129) | 3.26380130 |
| 24 | Hand muscle atrophy (HP:0009130) | 3.22163435 |
| 25 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.16902289 |
| 26 | Albinism (HP:0001022) | 3.13274882 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.11814752 |
| 28 | Cerebral edema (HP:0002181) | 3.07358804 |
| 29 | Hepatic necrosis (HP:0002605) | 3.07300058 |
| 30 | Acute encephalopathy (HP:0006846) | 3.05839572 |
| 31 | Abnormality of serum amino acid levels (HP:0003112) | 3.05148726 |
| 32 | Lethargy (HP:0001254) | 3.04423936 |
| 33 | Brushfield spots (HP:0001088) | 3.03838070 |
| 34 | Hyperphosphatemia (HP:0002905) | 3.00097059 |
| 35 | Hyperbilirubinemia (HP:0002904) | 2.96493364 |
| 36 | Hepatocellular necrosis (HP:0001404) | 2.93778796 |
| 37 | Complement deficiency (HP:0004431) | 2.93432585 |
| 38 | Delayed CNS myelination (HP:0002188) | 2.89928805 |
| 39 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.86378835 |
| 40 | Premature rupture of membranes (HP:0001788) | 2.83594671 |
| 41 | Late onset (HP:0003584) | 2.82496214 |
| 42 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.77821691 |
| 43 | Dicarboxylic aciduria (HP:0003215) | 2.77821691 |
| 44 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.76243034 |
| 45 | Asymmetric septal hypertrophy (HP:0001670) | 2.74429026 |
| 46 | Severe visual impairment (HP:0001141) | 2.72193452 |
| 47 | Thin bony cortex (HP:0002753) | 2.70326898 |
| 48 | Protrusio acetabuli (HP:0003179) | 2.68460166 |
| 49 | Nuclear cataract (HP:0100018) | 2.67022507 |
| 50 | Hypolipoproteinemia (HP:0010981) | 2.64649591 |
| 51 | CNS demyelination (HP:0007305) | 2.64047277 |
| 52 | Acute necrotizing encephalopathy (HP:0006965) | 2.63559138 |
| 53 | Abnormality of the intrinsic pathway (HP:0010989) | 2.62936129 |
| 54 | Increased muscle lipid content (HP:0009058) | 2.62790510 |
| 55 | Ragged-red muscle fibers (HP:0003200) | 2.61183856 |
| 56 | Abnormal gallbladder morphology (HP:0012437) | 2.61023642 |
| 57 | Cholelithiasis (HP:0001081) | 2.60025793 |
| 58 | Mucopolysacchariduria (HP:0008155) | 2.55419940 |
| 59 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.55419940 |
| 60 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.49599006 |
| 61 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.49599006 |
| 62 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.49599006 |
| 63 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.46019742 |
| 64 | Fat malabsorption (HP:0002630) | 2.45813924 |
| 65 | Progressive macrocephaly (HP:0004481) | 2.44206598 |
| 66 | Cerebral hypomyelination (HP:0006808) | 2.43688564 |
| 67 | Systemic lupus erythematosus (HP:0002725) | 2.43238373 |
| 68 | Spastic paraparesis (HP:0002313) | 2.43155798 |
| 69 | Increased intramyocellular lipid droplets (HP:0012240) | 2.42300221 |
| 70 | Global brain atrophy (HP:0002283) | 2.41972800 |
| 71 | Mitochondrial inheritance (HP:0001427) | 2.41316326 |
| 72 | Hemorrhage of the eye (HP:0011885) | 2.41212387 |
| 73 | Polycythemia (HP:0001901) | 2.40091295 |
| 74 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.37294941 |
| 75 | Dysostosis multiplex (HP:0000943) | 2.35345416 |
| 76 | Progressive muscle weakness (HP:0003323) | 2.35243261 |
| 77 | Abnormality of the common coagulation pathway (HP:0010990) | 2.33055324 |
| 78 | Atelectasis (HP:0100750) | 2.28433880 |
| 79 | Increased CSF lactate (HP:0002490) | 2.26429153 |
| 80 | Neuronal loss in central nervous system (HP:0002529) | 2.25590696 |
| 81 | Distal lower limb muscle weakness (HP:0009053) | 2.24827732 |
| 82 | Lactic acidosis (HP:0003128) | 2.23520124 |
| 83 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.23073962 |
| 84 | Irritability (HP:0000737) | 2.21808370 |
| 85 | Cervical subluxation (HP:0003308) | 2.21099056 |
| 86 | Hyperglycemia (HP:0003074) | 2.20612211 |
| 87 | Abnormality of the nasal mucosa (HP:0000433) | 2.20199922 |
| 88 | Abnormality of purine metabolism (HP:0004352) | 2.20108692 |
| 89 | Abnormality of methionine metabolism (HP:0010901) | 2.17247208 |
| 90 | Glycosuria (HP:0003076) | 2.15452958 |
| 91 | Abnormality of urine glucose concentration (HP:0011016) | 2.15452958 |
| 92 | Lipid accumulation in hepatocytes (HP:0006561) | 2.14935296 |
| 93 | Metabolic acidosis (HP:0001942) | 2.14119006 |
| 94 | Conjugated hyperbilirubinemia (HP:0002908) | 2.13724001 |
| 95 | Abnormality of nucleobase metabolism (HP:0010932) | 2.12709383 |
| 96 | Delusions (HP:0000746) | 2.11632102 |
| 97 | Ocular albinism (HP:0001107) | 2.09977758 |
| 98 | Loss of speech (HP:0002371) | 2.09803595 |
| 99 | Vomiting (HP:0002013) | 2.09342694 |
| 100 | Joint hemorrhage (HP:0005261) | 2.09335511 |
| 101 | Stridor (HP:0010307) | 2.08826505 |
| 102 | Hypoglycemic seizures (HP:0002173) | 2.08717618 |
| 103 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.08492695 |
| 104 | Cerebral aneurysm (HP:0004944) | 2.07522025 |
| 105 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.05580389 |
| 106 | Nasal polyposis (HP:0100582) | 2.05453221 |
| 107 | Neonatal onset (HP:0003623) | 2.03690154 |
| 108 | Increased connective tissue (HP:0009025) | 2.03591066 |
| 109 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.03436977 |
| 110 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.03436977 |
| 111 | Supranuclear gaze palsy (HP:0000605) | 2.03013581 |
| 112 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.00602840 |
| 113 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.00602840 |
| 114 | Abnormality of glycolipid metabolism (HP:0010969) | 2.00602840 |
| 115 | Vertebral compression fractures (HP:0002953) | 1.99968439 |
| 116 | Peripheral hypomyelination (HP:0007182) | 1.98702021 |
| 117 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.97910767 |
| 118 | Restlessness (HP:0000711) | 1.97729992 |
| 119 | Abnormality of complement system (HP:0005339) | 1.97282537 |
| 120 | Skin nodule (HP:0200036) | 1.97034247 |
| 121 | Rhabdomyolysis (HP:0003201) | 1.95762721 |
| 122 | Neurofibrillary tangles (HP:0002185) | 1.95701173 |
| 123 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.94934488 |
| 124 | Reticulocytosis (HP:0001923) | 1.93658887 |
| 125 | J-shaped sella turcica (HP:0002680) | 1.93432754 |
| 126 | Increased serum pyruvate (HP:0003542) | 1.93017134 |
| 127 | Abnormality of glycolysis (HP:0004366) | 1.93017134 |
| 128 | Hypoalphalipoproteinemia (HP:0003233) | 1.92446354 |
| 129 | Spontaneous abortion (HP:0005268) | 1.91710835 |
| 130 | Achilles tendon contracture (HP:0001771) | 1.91484375 |
| 131 | Progressive neurologic deterioration (HP:0002344) | 1.91383733 |
| 132 | Distal lower limb amyotrophy (HP:0008944) | 1.90374220 |
| 133 | Abnormality of the gallbladder (HP:0005264) | 1.89864542 |
| 134 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.88776320 |
| 135 | Hammertoe (HP:0001765) | 1.88158463 |
| 136 | Interstitial pulmonary disease (HP:0006530) | 1.87214471 |
| 137 | Opisthotonus (HP:0002179) | 1.87075724 |
| 138 | Prolonged neonatal jaundice (HP:0006579) | 1.86984480 |
| 139 | Generalized aminoaciduria (HP:0002909) | 1.86484557 |
| 140 | Bell-shaped thorax (HP:0001591) | 1.86430032 |
| 141 | Cerebral inclusion bodies (HP:0100314) | 1.86348056 |
| 142 | Malnutrition (HP:0004395) | 1.84364156 |
| 143 | Increased purine levels (HP:0004368) | 1.84260318 |
| 144 | Hyperuricemia (HP:0002149) | 1.84260318 |
| 145 | Respiratory failure (HP:0002878) | 1.84182011 |
| 146 | Aneurysm (HP:0002617) | 1.83764231 |
| 147 | Steatorrhea (HP:0002570) | 1.83506762 |
| 148 | Ankle clonus (HP:0011448) | 1.83415497 |
| 149 | Amyloidosis (HP:0011034) | 1.82401690 |
| 150 | Abnormality of the Achilles tendon (HP:0005109) | 1.79756855 |
| 151 | Increased CSF protein (HP:0002922) | 1.79202668 |
| 152 | CNS hypomyelination (HP:0003429) | 1.78539635 |
| 153 | Abnormality of the periventricular white matter (HP:0002518) | 1.77953291 |
| 154 | Emotional lability (HP:0000712) | 1.76693350 |
| 155 | Increased serum lactate (HP:0002151) | 1.75843898 |
| 156 | Hyperthyroidism (HP:0000836) | 1.75320520 |
| 157 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.75313177 |
| 158 | Tetraparesis (HP:0002273) | 1.72975803 |
| 159 | Hyperphosphaturia (HP:0003109) | 1.72848227 |
| 160 | Conjunctival hamartoma (HP:0100780) | 1.72742703 |
| 161 | Decreased motor nerve conduction velocity (HP:0003431) | 1.71283602 |
| 162 | Abnormality of the acetabulum (HP:0003170) | 1.71214656 |
| 163 | Upper limb muscle weakness (HP:0003484) | 1.70338003 |
| 164 | Slow saccadic eye movements (HP:0000514) | 1.70090807 |
| 165 | Hypertensive crisis (HP:0100735) | 1.69573973 |
| 166 | Short nail (HP:0001799) | 1.68486829 |
| 167 | Easy fatigability (HP:0003388) | 1.66955387 |
| 168 | Hyperparathyroidism (HP:0000843) | 1.66781498 |
| 169 | Osteolytic defects of the hand bones (HP:0009699) | 1.65009551 |
| 170 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.65009551 |
| 171 | Hypertriglyceridemia (HP:0002155) | 1.64684960 |
| 172 | Axonal loss (HP:0003447) | 1.63977648 |
| 173 | Onion bulb formation (HP:0003383) | 1.63415717 |
| 174 | Aortic aneurysm (HP:0004942) | 1.62304392 |
| 175 | Iris hypopigmentation (HP:0007730) | 1.61808471 |
| 176 | Back pain (HP:0003418) | 1.61585350 |
| 177 | Abnormality of molar morphology (HP:0011070) | 1.61575493 |
| 178 | Abnormality of molar (HP:0011077) | 1.61575493 |
| 179 | Purpura (HP:0000979) | 1.60937176 |
| 180 | Abnormality of the dental root (HP:0006486) | 1.58534893 |
| 181 | Taurodontia (HP:0000679) | 1.58534893 |
| 182 | Abnormality of permanent molar morphology (HP:0011071) | 1.58534893 |
| 183 | Abdominal distention (HP:0003270) | 1.57887952 |
| 184 | Spinal rigidity (HP:0003306) | 1.57481251 |
| 185 | Bradycardia (HP:0001662) | 1.55459312 |
| 186 | Increased variability in muscle fiber diameter (HP:0003557) | 1.54914953 |
| 187 | Hyperacusis (HP:0010780) | 1.54649710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.24773345 |
| 2 | FRK | 3.66277990 |
| 3 | TAOK2 | 3.32442705 |
| 4 | TESK1 | 3.29259824 |
| 5 | BUB1 | 3.07290963 |
| 6 | TLK1 | 3.07031311 |
| 7 | MAP2K3 | 3.02126280 |
| 8 | MAP3K3 | 2.71084933 |
| 9 | TAOK1 | 2.60960191 |
| 10 | RIPK1 | 2.49205061 |
| 11 | PRPF4B | 2.45525508 |
| 12 | STK16 | 2.39181756 |
| 13 | NME2 | 2.36651405 |
| 14 | FGFR2 | 2.34649226 |
| 15 | WEE1 | 2.20324706 |
| 16 | BRD4 | 2.11343515 |
| 17 | BRSK2 | 1.96209649 |
| 18 | DYRK3 | 1.93343515 |
| 19 | EPHA2 | 1.81831451 |
| 20 | DMPK | 1.75597365 |
| 21 | TRIB3 | 1.71325034 |
| 22 | AKT3 | 1.68619163 |
| 23 | DDR2 | 1.67050283 |
| 24 | MUSK | 1.61759572 |
| 25 | INSRR | 1.59043715 |
| 26 | RIPK4 | 1.54385275 |
| 27 | STK39 | 1.53278951 |
| 28 | JAK3 | 1.52091574 |
| 29 | CSNK1G3 | 1.50426182 |
| 30 | PHKG2 | 1.49978329 |
| 31 | PHKG1 | 1.49978329 |
| 32 | MET | 1.49733622 |
| 33 | EPHB1 | 1.46984952 |
| 34 | PINK1 | 1.46420666 |
| 35 | MAP2K2 | 1.44314296 |
| 36 | BMPR2 | 1.43255650 |
| 37 | EIF2AK1 | 1.36504736 |
| 38 | NME1 | 1.34782140 |
| 39 | PRKD3 | 1.31786731 |
| 40 | MST1R | 1.30049548 |
| 41 | ERN1 | 1.27368506 |
| 42 | SIK3 | 1.25592760 |
| 43 | LMTK2 | 1.18153001 |
| 44 | CSNK1G1 | 1.17108661 |
| 45 | PRKD2 | 1.15198145 |
| 46 | ABL2 | 1.11752525 |
| 47 | MAP3K2 | 1.11326669 |
| 48 | PDK3 | 1.10472620 |
| 49 | PDK4 | 1.10472620 |
| 50 | CDK19 | 1.10440732 |
| 51 | TYK2 | 1.09838640 |
| 52 | CSNK1G2 | 1.08309458 |
| 53 | OXSR1 | 1.07642672 |
| 54 | CDK12 | 1.05673594 |
| 55 | FES | 1.04953021 |
| 56 | PRKG2 | 1.01051487 |
| 57 | RPS6KA2 | 0.99193287 |
| 58 | MARK2 | 0.99108917 |
| 59 | MAP2K4 | 0.98967876 |
| 60 | CDC42BPA | 0.98754982 |
| 61 | RAF1 | 0.98098725 |
| 62 | WNK4 | 0.97814189 |
| 63 | CSNK1A1L | 0.97089039 |
| 64 | CDK8 | 0.96985565 |
| 65 | LATS2 | 0.95659957 |
| 66 | TESK2 | 0.93861842 |
| 67 | KSR2 | 0.91668522 |
| 68 | CLK1 | 0.90975242 |
| 69 | TBK1 | 0.90195871 |
| 70 | ACVR1B | 0.90031340 |
| 71 | BRAF | 0.89809379 |
| 72 | TIE1 | 0.89330666 |
| 73 | BRSK1 | 0.88328829 |
| 74 | MAP3K8 | 0.88136268 |
| 75 | BLK | 0.87948719 |
| 76 | EIF2AK3 | 0.87845364 |
| 77 | PDGFRA | 0.87030689 |
| 78 | PDK1 | 0.86656362 |
| 79 | MAPKAPK5 | 0.85048225 |
| 80 | CCNB1 | 0.84129523 |
| 81 | ZAP70 | 0.83268019 |
| 82 | MAP3K13 | 0.83058342 |
| 83 | IRAK3 | 0.82836549 |
| 84 | ARAF | 0.82107913 |
| 85 | LIMK1 | 0.81734389 |
| 86 | PTK6 | 0.81250976 |
| 87 | DYRK2 | 0.80154560 |
| 88 | EEF2K | 0.79803174 |
| 89 | NTRK1 | 0.78410481 |
| 90 | MAP3K11 | 0.77238132 |
| 91 | TNK2 | 0.75721857 |
| 92 | PIM2 | 0.74777857 |
| 93 | TNIK | 0.74141885 |
| 94 | SMG1 | 0.73949891 |
| 95 | PAK3 | 0.73872824 |
| 96 | BMX | 0.72724698 |
| 97 | PKN2 | 0.71505700 |
| 98 | STK11 | 0.71391094 |
| 99 | ICK | 0.71381397 |
| 100 | SIK1 | 0.71042627 |
| 101 | TAOK3 | 0.70720872 |
| 102 | PTK2B | 0.70131647 |
| 103 | MAP3K1 | 0.70069838 |
| 104 | DYRK1B | 0.67324945 |
| 105 | AURKA | 0.67193182 |
| 106 | MTOR | 0.66997831 |
| 107 | MAPKAPK3 | 0.66018480 |
| 108 | HIPK2 | 0.65995878 |
| 109 | ERBB2 | 0.64681009 |
| 110 | MAPK11 | 0.64233216 |
| 111 | JAK2 | 0.63039617 |
| 112 | PRKCI | 0.62105014 |
| 113 | MAPK15 | 0.60525589 |
| 114 | MAP3K5 | 0.59196806 |
| 115 | RET | 0.58630636 |
| 116 | MKNK1 | 0.58401492 |
| 117 | PAK6 | 0.57838040 |
| 118 | FLT3 | 0.56509086 |
| 119 | PRKAA1 | 0.56407155 |
| 120 | NEK2 | 0.55794310 |
| 121 | STK38 | 0.54932761 |
| 122 | PNCK | 0.54247016 |
| 123 | JAK1 | 0.53453441 |
| 124 | EPHA4 | 0.52252309 |
| 125 | PRKD1 | 0.51635782 |
| 126 | NEK1 | 0.51246213 |
| 127 | MAPK12 | 0.51085519 |
| 128 | PAK4 | 0.49978334 |
| 129 | UHMK1 | 0.49539523 |
| 130 | MOS | 0.49463052 |
| 131 | ROCK2 | 0.48657805 |
| 132 | MAP2K1 | 0.48418157 |
| 133 | TGFBR2 | 0.47474081 |
| 134 | RPS6KC1 | 0.47282826 |
| 135 | RPS6KL1 | 0.47282826 |
| 136 | MYLK | 0.46607672 |
| 137 | STK38L | 0.46378841 |
| 138 | NEK6 | 0.45912913 |
| 139 | MKNK2 | 0.45632858 |
| 140 | CAMK2G | 0.44977055 |
| 141 | OBSCN | 0.44888967 |
| 142 | PDPK1 | 0.44609024 |
| 143 | PAK2 | 0.44519862 |
| 144 | FER | 0.42381332 |
| 145 | AKT2 | 0.42342750 |
| 146 | TTN | 0.41895393 |
| 147 | CSNK1E | 0.40963297 |
| 148 | TSSK6 | 0.40795716 |
| 149 | EPHA3 | 0.40232896 |
| 150 | PASK | 0.40194197 |
| 151 | PRKCG | 0.39738329 |
| 152 | PIK3CG | 0.39712517 |
| 153 | TGFBR1 | 0.39480201 |
| 154 | DYRK1A | 0.39460003 |
| 155 | MST4 | 0.38852786 |
| 156 | FGFR4 | 0.38398658 |
| 157 | MAP3K7 | 0.38393825 |
| 158 | PTK2 | 0.37248414 |
| 159 | PRKACB | 0.37196277 |
| 160 | PAK1 | 0.37104925 |
| 161 | PRKAA2 | 0.37061136 |
| 162 | ROCK1 | 0.36694961 |
| 163 | LRRK2 | 0.36150670 |
| 164 | SRC | 0.35552912 |
| 165 | SGK3 | 0.35165149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.98462074 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.91452030 |
| 3 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.84377959 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.69405106 |
| 5 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.68855376 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.54252671 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.52275983 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.49336929 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.33468363 |
| 10 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.21834352 |
| 11 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.16606893 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.14932812 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.11439243 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.07896920 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.06212623 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.05688967 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04003289 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.03182597 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.95928619 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.93088070 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.91199514 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.89373515 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.86982083 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.81422129 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.74658421 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71649028 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.63004405 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62141994 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.61897972 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60007794 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.57466539 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.53090124 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.50858194 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.50066769 |
| 35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.47647600 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46701640 |
| 37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.45086005 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.43511378 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42966859 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.42029572 |
| 41 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40798371 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.39852983 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.39024236 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.38794424 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35581232 |
| 46 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.35351405 |
| 47 | Protein export_Homo sapiens_hsa03060 | 1.34460964 |
| 48 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.33104492 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.30864615 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27186526 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.26598727 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.23059104 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20378621 |
| 54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.19208811 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 1.18899111 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.18850055 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.17745123 |
| 58 | Parkinsons disease_Homo sapiens_hsa05012 | 1.17347120 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15785058 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14933496 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.12780194 |
| 62 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.12195959 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.10423471 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.08804251 |
| 65 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.05799469 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.05249264 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03319889 |
| 68 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01981000 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01752662 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 1.01393983 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00136319 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.99715843 |
| 73 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.98681155 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.97937465 |
| 75 | RNA polymerase_Homo sapiens_hsa03020 | 0.97718320 |
| 76 | Leishmaniasis_Homo sapiens_hsa05140 | 0.97086278 |
| 77 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.96734273 |
| 78 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.96677957 |
| 79 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96178552 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.95808334 |
| 81 | Influenza A_Homo sapiens_hsa05164 | 0.94680843 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.94234827 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93955625 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93677116 |
| 85 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.92089703 |
| 86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.91130121 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.90087732 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.89274288 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.89268683 |
| 90 | Ribosome_Homo sapiens_hsa03010 | 0.89044872 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 0.88416106 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88120771 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.87918979 |
| 94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87515041 |
| 95 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.86829098 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.85925903 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | 0.85340681 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.83073673 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83013037 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.82936125 |
| 101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82874023 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82782809 |
| 103 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80150714 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80018997 |
| 105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.79299081 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.78497316 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.77633300 |
| 108 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.77083965 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76945293 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76380779 |
| 111 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.76150782 |
| 112 | Tuberculosis_Homo sapiens_hsa05152 | 0.75383709 |
| 113 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75259563 |
| 114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74490228 |
| 115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73662577 |
| 116 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.73542693 |
| 117 | ABC transporters_Homo sapiens_hsa02010 | 0.72908969 |
| 118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.72864680 |
| 119 | Glioma_Homo sapiens_hsa05214 | 0.72165862 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72153715 |
| 121 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.70905605 |
| 122 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.70623885 |
| 123 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70474127 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69452589 |
| 125 | Adherens junction_Homo sapiens_hsa04520 | 0.68451254 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.67941260 |
| 127 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67766305 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66913044 |
| 129 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.65581578 |
| 130 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65158704 |
| 131 | Salmonella infection_Homo sapiens_hsa05132 | 0.64969559 |
| 132 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63551123 |
| 133 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.61884463 |
| 134 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61603482 |
| 135 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60825872 |
| 136 | Huntingtons disease_Homo sapiens_hsa05016 | 0.60339129 |
| 137 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57978583 |
| 138 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57584366 |
| 139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57391760 |
| 140 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57374138 |
| 141 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55839245 |
| 142 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55731138 |
| 143 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55013982 |
| 144 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51745499 |
| 145 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50742283 |
| 146 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49420533 |
| 147 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49185630 |
| 148 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48864773 |
| 149 | Hepatitis B_Homo sapiens_hsa05161 | 0.48159217 |
| 150 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.48108701 |
| 151 | Platelet activation_Homo sapiens_hsa04611 | 0.48081155 |
| 152 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47002828 |
| 153 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46830510 |
| 154 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45358405 |
| 155 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.39505533 |
| 156 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39464712 |
| 157 | Lysine degradation_Homo sapiens_hsa00310 | 0.36783552 |
| 158 | Proteasome_Homo sapiens_hsa03050 | 0.35259353 |
| 159 | Prion diseases_Homo sapiens_hsa05020 | 0.34657133 |
| 160 | Purine metabolism_Homo sapiens_hsa00230 | 0.31728690 |
| 161 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28826626 |
| 162 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.28408280 |
| 163 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26562002 |
| 164 | Insulin secretion_Homo sapiens_hsa04911 | 0.24592740 |
| 165 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.19296427 |
| 166 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.18246444 |
| 167 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.12729699 |
| 168 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.12493035 |
| 169 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11262370 |
| 170 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.10207281 |
| 171 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.09934387 |
| 172 | Cocaine addiction_Homo sapiens_hsa05030 | 0.06461908 |

